Illumina Expands Product Portfolio to Support Oncology Clinical Research and Discovery End-to-End Genomics Solutions Will Transform the Future of Oncology SAN DIEGO–(BUSINESS WIRE)–Apr. 2, 2014– Illumina, Inc. (NASDAQ:ILMN) today announced new products that can be applied directly to the discovery ...
Read More »